Drugs for Neglected Diseases initiative - DNDi
Helen Standring is an experienced professional in prospect research and fundraising, currently serving as the Prospect Research Manager at the Drugs for Neglected Diseases initiative - DNDi since February 2025. Previously held the role of Philanthropy Research Manager at Historic Royal Palaces from June 2023 to January 2025 and served as Senior Prospect Researcher at Cats Protection from October 2021 to June 2023. Helen's earlier positions include Fundraising Research Manager at the University of London, Head of Development Operations at the Royal College of Music, and Head of Research and Analytics at the Science Museum Group, among other roles. Helen's educational background includes a BA (Hons) in Politics & Sociology from the University of Leeds, an MSc in Gender, Society & Culture from Birkbeck College, and a Postgraduate Diploma in Research Methods in the Social Sciences from Middlesex University.
This person is not in any teams
This person is not in any offices
Drugs for Neglected Diseases initiative - DNDi
2 followers
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.